Innovus Pharmaceuticals Inc Aktie OTC Bulletin Board
Aktien
US45778V1061
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager | Titel | Alter | Seit |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01.06.18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
% 1. Jan. | Kap. | |
---|---|---|
+55.32% | 815 Mrd. | |
+42.53% | 641 Mrd. | |
-6.75% | 352 Mrd. | |
+13.56% | 314 Mrd. | |
+10.68% | 303 Mrd. | |
+15.47% | 242 Mrd. | |
+1.92% | 224 Mrd. | |
+13.26% | 218 Mrd. | |
+8.48% | 168 Mrd. |